| Topics | Speakers | Time | Venue |
|---|---|---|---|
| <span>in</span>-congress opening, first day, interventional | |||
| Participants registration | 8.00 | ||
| Greetings Local Authorities | 9.03-9.13 | ||
| Insubria: roots and perspectives of a young University on its 25th anniversary | 9.15-9.20 | ||
| Greetings SIRM Authorities | 9.20-9.33 | ||
| Greetings in-Presidents | 9.33-9.45 | ||
| <span>in</span>-key honorary lecture A | 9.45-9.58 | lecture | |
| <span>in</span>-session 1 | 10.00-10.44 | ||
| Percutaneous vs laparoscopic open ablation in colorectal liver metastases management | 10.00 | ||
| Balloon-occluded ablation and TACE in unresectable, large HCC | 10.11 | ||
| Ablation and immunotherapy in lung tumours | 10.22 | ||
| Ablation and surgery in malignant thyroid tumours management | 10.33 | ||
| General Discussion | 10.44 | ||
| <span>in</span>-session 2 | 11.00-11.44 | ||
| Glass vs Resin vs Holmium microspheres in TARE for HCC | 11.00 | ||
| DSM-TACE vs immunotherapy vs Sorafenib in intermediate HCC | 11.11 | ||
| TACE vs TARE vs combined approaches in unresectable cholangiocarcinoma | 11.22 | ||
| MWA vs RFA vs cryoablation in renal tumours | 11.33 | ||
| General Discussion | 11.44 | ||
| <span>in</span>-session 3 | 12.00-12.44 | ||
| Fusion imaging, augmented reality and new guidance systems in interventional oncology | 12.00 | ||
| Future perspectives in microballoon interventions of liver tumours | 12.11 | ||
| Future perspectives in TARE and combined approaches in liver metastases | 12.22 | ||
| Future perspectives in ablation techniques and combined approaches in solid tumours | 12.33 | ||
| General Discussion | 12.44 | ||
| <span>in</span>-key honorary lecture B | 13.00-13.13 | lecture | |
| Lunch | 13.13-13.58 |